HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis.

Abstract
TLR-dependent signal transduction pathways were analyzed in patients with a diagnosis of either relapsing-remitting (RRMS), secondary progressive (PMS) or benign (BMS) MS and healthy controls (HC). Prototypical TLR molecules expressed either on the cell surface (TLR4) or intracellularly (TLR3) were stimulated with specific antigens (LPS and poly I:C, respectively). Expression of factors involved in TLR signaling cascades, production of downstream immune mediators and TLR expression were evaluated. Results showed that, whereas LPS-stimulation of TLR4 had a marginal effect on cell activation, poly I:C-stimulated TLR3 expression on immune cells was significantly increased in PMS and BMS compared to HC. This was associated with a higher responsiveness to poly I:C that resulted in the activation of the TLR3-mediated pathway and the production of inflammatory cytokines in PMS and, in contrast, in the up-regulation of a peculiar mosaic of inflammation-dampening genes in BMS. Results herein might explain different MS disease phenotypes.
AuthorsMarina Saresella, Andrea Gatti, Paola Tortorella, Ivana Marventano, Federica Piancone, Francesca La Rosa, Domenico Caputo, Marco Rovaris, Mara Biasin, Mario Clerici
JournalClinical immunology (Orlando, Fla.) (Clin Immunol) Vol. 150 Issue 1 Pg. 109-20 (Jan 2014) ISSN: 1521-7035 [Electronic] United States
PMID24334148 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013. Published by Elsevier Inc.
Chemical References
  • Lipopolysaccharides
  • TLR3 protein, human
  • TLR4 protein, human
  • Toll-Like Receptor 3
  • Toll-Like Receptor 4
  • Poly I-C
Topics
  • Adult
  • Cells, Cultured
  • Female
  • Humans
  • Inflammation (immunology)
  • Leukocytes, Mononuclear (immunology)
  • Lipopolysaccharides
  • Male
  • Middle Aged
  • Multiple Sclerosis (immunology)
  • Phenotype
  • Poly I-C
  • Toll-Like Receptor 3 (agonists, immunology)
  • Toll-Like Receptor 4 (agonists, immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: